Leerink Partners-MA Advisory Executives shaking hands in a board room

M&A ADVISORY

Expert Advice and Discerning Judgement

CONTACT US
OUR FOCUS

Creating Value-Driven Opportunities

Our highly-experienced investment bankers draw on their deep knowledge of the healthcare industry and unique market dynamics to help business leaders evaluate strategic alternatives and successfully execute complex, transformative transactions.

Our capabilities encompass both buy-side and sell-side advisory, strategic partnerships, joint ventures, and divestitures, including corporate carve-outs. Since 2009, we have completed 200+ M&A transactions with an aggregate value of $60B.

Leerink Partners Biopharma Background Image

Recent Transactions

Undisclosed
Financial Advisor
Global License Agreement with Biosion
November 2024
Undisclosed
Exclusive Financial Advisor
AlloVir Merger with Kalaris Therapeutics
November 2024
UNDISCLOSED
Exclusive Financial Advisor
Acquisition of Opus Genetics, Inc.
October 2024
UNDISCLOSED
Exclusive Financial Advisor
Acquisition of Global Rights to BRM-1420 from Bridge Medicines
October 2024
View all Transactions
Banner desktop

Partner With Us

Let us help you achieve your strategic,
capital markets, and investment objectives

Contact Us

Our experienced team is happy to assist you. Please complete the form below and we’ll be in touch as soon as possible. *” indicates required fields

This field is for validation purposes and should be left unchanged.